Virus and Antibody Dynamics in Acute West Nile Virus Infection
Background. The dynamics of the early stages of West Nile virus (WNV) infection can be assessed by follow-up studies of viremic blood donors. Methods. A total of 245 donors with WNV viremia were followed up weekly for 4 weeks and then monthly for up to 6 additional months or until seroconversion. Pl...
Gespeichert in:
Veröffentlicht in: | The Journal of infectious diseases 2008-10, Vol.198 (7), p.984-993 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 993 |
---|---|
container_issue | 7 |
container_start_page | 984 |
container_title | The Journal of infectious diseases |
container_volume | 198 |
creator | Busch, Michael P. Kleinman, Steven H. Tobler, Leslie H. Kamel, Hany T. Norris, Philip J. Walsh, Irina Matud, Jose L. Prince, Harry E. Lanciotti, Robert S. Wright, David J. Linnen, Jeffrey M. Caglioti, Sally |
description | Background. The dynamics of the early stages of West Nile virus (WNV) infection can be assessed by follow-up studies of viremic blood donors. Methods. A total of 245 donors with WNV viremia were followed up weekly for 4 weeks and then monthly for up to 6 additional months or until seroconversion. Plasma samples were tested for WNV RNA by transcription-mediated amplification (TMA) and for WNV-specific IgM and IgG antibodies. RNA persistence was investigated by 6 replicate TMA tests; samples that were viremic for $gt; 40 days were tested for WNV-neutralizing activity. Follow up of 35 additional viremic donors for up to 404 days was conducted to evaluate persistence of WNV-specific antibody. Results. The median time from RNA detection to IgM seroconversion was 3.9 days; to IgG seroconversion, 7.7 days; to RNA negativity by single-replicate TMA, 13.2 days; and to RNA negativity by 6-replicate TMA, 6.1 additional days after results of single-replicate TMA are negative. For 4 donors in whom RNA persisted for > 40 days after the index donation, all samples obtained after this threshold were also positive for WNV IgG and neutralizing activity. The mean times to IgM and IgA negativity were 156 and 220 days, respectively. Conclusions. IgM and IgG develop rapidly after viremia and before RNA levels become undetectable, which occurred a mean of 13.2 days after the index donation among donors in this study. WNV RNA detection by replicate TMA rarely persists for > 40 days after the index donation and is accompanied by WNV-specific neutralizing antibody, consistent with an absence of WNV transmission via transfusion of seropositive blood components. |
doi_str_mv | 10.1086/591467 |
format | Article |
fullrecord | <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_69522093</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>40254224</jstor_id><sourcerecordid>40254224</sourcerecordid><originalsourceid>FETCH-LOGICAL-c430t-32d67c5d6c6022ee38bb2b48e52d75266821e4dee66894843f6c1d3535d027953</originalsourceid><addsrcrecordid>eNqF0E1r3DAQBmARWpJt2v6DFl_Sm9vR6PtSWNKPBEJKoU1CLkKWZFDqtTeSDd1_Xwcvm2NPGngfhtFLyFsKHylo-UkYyqU6IisqmKqlpOwFWQEg1lQbc0JelfIAAJxJdUxOqFZolGYr8vkm5alUrg_Vuh9TM4Rd9WXXu03ypUp9tfbTGKvbWMbqOnWxWvhl30Y_pqF_TV62rivxzf49Jb-_ff11flFf_fh-eb6-qj1nMNYMg1ReBOnlfFKMTDcNNlxHgUEJlFIjjTzEOE-Ga85a6WlggokAqIxgp-TDsnebh8dpvsZuUvGx61wfh6lYaQQiGPZfiBQ4aoBn6PNQSo6t3ea0cXlnKdinSu1S6Qzf7zdOzSaGZ7bvcAZne-CKd12bXe9TOTgEKRiDJ_ducQ9lHPIh54CCI_I5r5c8lTH-PeQu_7HzGUrYi7t7y29_3pj5o_aa_QOehJKk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>21042800</pqid></control><display><type>article</type><title>Virus and Antibody Dynamics in Acute West Nile Virus Infection</title><source>MEDLINE</source><source>JSTOR Archive Collection A-Z Listing</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Alma/SFX Local Collection</source><creator>Busch, Michael P. ; Kleinman, Steven H. ; Tobler, Leslie H. ; Kamel, Hany T. ; Norris, Philip J. ; Walsh, Irina ; Matud, Jose L. ; Prince, Harry E. ; Lanciotti, Robert S. ; Wright, David J. ; Linnen, Jeffrey M. ; Caglioti, Sally</creator><creatorcontrib>Busch, Michael P. ; Kleinman, Steven H. ; Tobler, Leslie H. ; Kamel, Hany T. ; Norris, Philip J. ; Walsh, Irina ; Matud, Jose L. ; Prince, Harry E. ; Lanciotti, Robert S. ; Wright, David J. ; Linnen, Jeffrey M. ; Caglioti, Sally</creatorcontrib><description>Background. The dynamics of the early stages of West Nile virus (WNV) infection can be assessed by follow-up studies of viremic blood donors. Methods. A total of 245 donors with WNV viremia were followed up weekly for 4 weeks and then monthly for up to 6 additional months or until seroconversion. Plasma samples were tested for WNV RNA by transcription-mediated amplification (TMA) and for WNV-specific IgM and IgG antibodies. RNA persistence was investigated by 6 replicate TMA tests; samples that were viremic for $gt; 40 days were tested for WNV-neutralizing activity. Follow up of 35 additional viremic donors for up to 404 days was conducted to evaluate persistence of WNV-specific antibody. Results. The median time from RNA detection to IgM seroconversion was 3.9 days; to IgG seroconversion, 7.7 days; to RNA negativity by single-replicate TMA, 13.2 days; and to RNA negativity by 6-replicate TMA, 6.1 additional days after results of single-replicate TMA are negative. For 4 donors in whom RNA persisted for > 40 days after the index donation, all samples obtained after this threshold were also positive for WNV IgG and neutralizing activity. The mean times to IgM and IgA negativity were 156 and 220 days, respectively. Conclusions. IgM and IgG develop rapidly after viremia and before RNA levels become undetectable, which occurred a mean of 13.2 days after the index donation among donors in this study. WNV RNA detection by replicate TMA rarely persists for > 40 days after the index donation and is accompanied by WNV-specific neutralizing antibody, consistent with an absence of WNV transmission via transfusion of seropositive blood components.</description><identifier>ISSN: 0022-1899</identifier><identifier>EISSN: 1537-6613</identifier><identifier>DOI: 10.1086/591467</identifier><identifier>PMID: 18729783</identifier><identifier>CODEN: JIDIAQ</identifier><language>eng</language><publisher>Chicago, IL: The University of Chicago Press</publisher><subject>Acute Disease ; Antibodies ; Antibodies, Viral - blood ; Biological and medical sciences ; Blood ; Blood donation ; Blood Donors ; Blood transfusion ; Disease transmission ; Fundamental and applied biological sciences. Psychology ; Humans ; Infections ; Infectious diseases ; Medical sciences ; Microbiology ; Miscellaneous ; Neutralization Tests ; Nucleic Acid Amplification Techniques ; RNA ; RNA, Viral - blood ; Specimens ; Transfusion Reaction ; Viremia ; Virology ; Viruses ; West Nile Fever - immunology ; West Nile Fever - virology ; West Nile virus ; West Nile virus - immunology ; West Nile virus - isolation & purification</subject><ispartof>The Journal of infectious diseases, 2008-10, Vol.198 (7), p.984-993</ispartof><rights>Copyright 2008 Infectious Diseases Society of America</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c430t-32d67c5d6c6022ee38bb2b48e52d75266821e4dee66894843f6c1d3535d027953</citedby><cites>FETCH-LOGICAL-c430t-32d67c5d6c6022ee38bb2b48e52d75266821e4dee66894843f6c1d3535d027953</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/40254224$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/40254224$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>315,781,785,804,27926,27927,58019,58252</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20653303$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18729783$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Busch, Michael P.</creatorcontrib><creatorcontrib>Kleinman, Steven H.</creatorcontrib><creatorcontrib>Tobler, Leslie H.</creatorcontrib><creatorcontrib>Kamel, Hany T.</creatorcontrib><creatorcontrib>Norris, Philip J.</creatorcontrib><creatorcontrib>Walsh, Irina</creatorcontrib><creatorcontrib>Matud, Jose L.</creatorcontrib><creatorcontrib>Prince, Harry E.</creatorcontrib><creatorcontrib>Lanciotti, Robert S.</creatorcontrib><creatorcontrib>Wright, David J.</creatorcontrib><creatorcontrib>Linnen, Jeffrey M.</creatorcontrib><creatorcontrib>Caglioti, Sally</creatorcontrib><title>Virus and Antibody Dynamics in Acute West Nile Virus Infection</title><title>The Journal of infectious diseases</title><addtitle>The Journal of Infectious Diseases</addtitle><description>Background. The dynamics of the early stages of West Nile virus (WNV) infection can be assessed by follow-up studies of viremic blood donors. Methods. A total of 245 donors with WNV viremia were followed up weekly for 4 weeks and then monthly for up to 6 additional months or until seroconversion. Plasma samples were tested for WNV RNA by transcription-mediated amplification (TMA) and for WNV-specific IgM and IgG antibodies. RNA persistence was investigated by 6 replicate TMA tests; samples that were viremic for $gt; 40 days were tested for WNV-neutralizing activity. Follow up of 35 additional viremic donors for up to 404 days was conducted to evaluate persistence of WNV-specific antibody. Results. The median time from RNA detection to IgM seroconversion was 3.9 days; to IgG seroconversion, 7.7 days; to RNA negativity by single-replicate TMA, 13.2 days; and to RNA negativity by 6-replicate TMA, 6.1 additional days after results of single-replicate TMA are negative. For 4 donors in whom RNA persisted for > 40 days after the index donation, all samples obtained after this threshold were also positive for WNV IgG and neutralizing activity. The mean times to IgM and IgA negativity were 156 and 220 days, respectively. Conclusions. IgM and IgG develop rapidly after viremia and before RNA levels become undetectable, which occurred a mean of 13.2 days after the index donation among donors in this study. WNV RNA detection by replicate TMA rarely persists for > 40 days after the index donation and is accompanied by WNV-specific neutralizing antibody, consistent with an absence of WNV transmission via transfusion of seropositive blood components.</description><subject>Acute Disease</subject><subject>Antibodies</subject><subject>Antibodies, Viral - blood</subject><subject>Biological and medical sciences</subject><subject>Blood</subject><subject>Blood donation</subject><subject>Blood Donors</subject><subject>Blood transfusion</subject><subject>Disease transmission</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Humans</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Medical sciences</subject><subject>Microbiology</subject><subject>Miscellaneous</subject><subject>Neutralization Tests</subject><subject>Nucleic Acid Amplification Techniques</subject><subject>RNA</subject><subject>RNA, Viral - blood</subject><subject>Specimens</subject><subject>Transfusion Reaction</subject><subject>Viremia</subject><subject>Virology</subject><subject>Viruses</subject><subject>West Nile Fever - immunology</subject><subject>West Nile Fever - virology</subject><subject>West Nile virus</subject><subject>West Nile virus - immunology</subject><subject>West Nile virus - isolation & purification</subject><issn>0022-1899</issn><issn>1537-6613</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0E1r3DAQBmARWpJt2v6DFl_Sm9vR6PtSWNKPBEJKoU1CLkKWZFDqtTeSDd1_Xwcvm2NPGngfhtFLyFsKHylo-UkYyqU6IisqmKqlpOwFWQEg1lQbc0JelfIAAJxJdUxOqFZolGYr8vkm5alUrg_Vuh9TM4Rd9WXXu03ypUp9tfbTGKvbWMbqOnWxWvhl30Y_pqF_TV62rivxzf49Jb-_ff11flFf_fh-eb6-qj1nMNYMg1ReBOnlfFKMTDcNNlxHgUEJlFIjjTzEOE-Ga85a6WlggokAqIxgp-TDsnebh8dpvsZuUvGx61wfh6lYaQQiGPZfiBQ4aoBn6PNQSo6t3ea0cXlnKdinSu1S6Qzf7zdOzSaGZ7bvcAZne-CKd12bXe9TOTgEKRiDJ_ducQ9lHPIh54CCI_I5r5c8lTH-PeQu_7HzGUrYi7t7y29_3pj5o_aa_QOehJKk</recordid><startdate>20081001</startdate><enddate>20081001</enddate><creator>Busch, Michael P.</creator><creator>Kleinman, Steven H.</creator><creator>Tobler, Leslie H.</creator><creator>Kamel, Hany T.</creator><creator>Norris, Philip J.</creator><creator>Walsh, Irina</creator><creator>Matud, Jose L.</creator><creator>Prince, Harry E.</creator><creator>Lanciotti, Robert S.</creator><creator>Wright, David J.</creator><creator>Linnen, Jeffrey M.</creator><creator>Caglioti, Sally</creator><general>The University of Chicago Press</general><general>University of Chicago Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7U9</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>20081001</creationdate><title>Virus and Antibody Dynamics in Acute West Nile Virus Infection</title><author>Busch, Michael P. ; Kleinman, Steven H. ; Tobler, Leslie H. ; Kamel, Hany T. ; Norris, Philip J. ; Walsh, Irina ; Matud, Jose L. ; Prince, Harry E. ; Lanciotti, Robert S. ; Wright, David J. ; Linnen, Jeffrey M. ; Caglioti, Sally</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c430t-32d67c5d6c6022ee38bb2b48e52d75266821e4dee66894843f6c1d3535d027953</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Acute Disease</topic><topic>Antibodies</topic><topic>Antibodies, Viral - blood</topic><topic>Biological and medical sciences</topic><topic>Blood</topic><topic>Blood donation</topic><topic>Blood Donors</topic><topic>Blood transfusion</topic><topic>Disease transmission</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Humans</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Medical sciences</topic><topic>Microbiology</topic><topic>Miscellaneous</topic><topic>Neutralization Tests</topic><topic>Nucleic Acid Amplification Techniques</topic><topic>RNA</topic><topic>RNA, Viral - blood</topic><topic>Specimens</topic><topic>Transfusion Reaction</topic><topic>Viremia</topic><topic>Virology</topic><topic>Viruses</topic><topic>West Nile Fever - immunology</topic><topic>West Nile Fever - virology</topic><topic>West Nile virus</topic><topic>West Nile virus - immunology</topic><topic>West Nile virus - isolation & purification</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Busch, Michael P.</creatorcontrib><creatorcontrib>Kleinman, Steven H.</creatorcontrib><creatorcontrib>Tobler, Leslie H.</creatorcontrib><creatorcontrib>Kamel, Hany T.</creatorcontrib><creatorcontrib>Norris, Philip J.</creatorcontrib><creatorcontrib>Walsh, Irina</creatorcontrib><creatorcontrib>Matud, Jose L.</creatorcontrib><creatorcontrib>Prince, Harry E.</creatorcontrib><creatorcontrib>Lanciotti, Robert S.</creatorcontrib><creatorcontrib>Wright, David J.</creatorcontrib><creatorcontrib>Linnen, Jeffrey M.</creatorcontrib><creatorcontrib>Caglioti, Sally</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Busch, Michael P.</au><au>Kleinman, Steven H.</au><au>Tobler, Leslie H.</au><au>Kamel, Hany T.</au><au>Norris, Philip J.</au><au>Walsh, Irina</au><au>Matud, Jose L.</au><au>Prince, Harry E.</au><au>Lanciotti, Robert S.</au><au>Wright, David J.</au><au>Linnen, Jeffrey M.</au><au>Caglioti, Sally</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Virus and Antibody Dynamics in Acute West Nile Virus Infection</atitle><jtitle>The Journal of infectious diseases</jtitle><addtitle>The Journal of Infectious Diseases</addtitle><date>2008-10-01</date><risdate>2008</risdate><volume>198</volume><issue>7</issue><spage>984</spage><epage>993</epage><pages>984-993</pages><issn>0022-1899</issn><eissn>1537-6613</eissn><coden>JIDIAQ</coden><abstract>Background. The dynamics of the early stages of West Nile virus (WNV) infection can be assessed by follow-up studies of viremic blood donors. Methods. A total of 245 donors with WNV viremia were followed up weekly for 4 weeks and then monthly for up to 6 additional months or until seroconversion. Plasma samples were tested for WNV RNA by transcription-mediated amplification (TMA) and for WNV-specific IgM and IgG antibodies. RNA persistence was investigated by 6 replicate TMA tests; samples that were viremic for $gt; 40 days were tested for WNV-neutralizing activity. Follow up of 35 additional viremic donors for up to 404 days was conducted to evaluate persistence of WNV-specific antibody. Results. The median time from RNA detection to IgM seroconversion was 3.9 days; to IgG seroconversion, 7.7 days; to RNA negativity by single-replicate TMA, 13.2 days; and to RNA negativity by 6-replicate TMA, 6.1 additional days after results of single-replicate TMA are negative. For 4 donors in whom RNA persisted for > 40 days after the index donation, all samples obtained after this threshold were also positive for WNV IgG and neutralizing activity. The mean times to IgM and IgA negativity were 156 and 220 days, respectively. Conclusions. IgM and IgG develop rapidly after viremia and before RNA levels become undetectable, which occurred a mean of 13.2 days after the index donation among donors in this study. WNV RNA detection by replicate TMA rarely persists for > 40 days after the index donation and is accompanied by WNV-specific neutralizing antibody, consistent with an absence of WNV transmission via transfusion of seropositive blood components.</abstract><cop>Chicago, IL</cop><pub>The University of Chicago Press</pub><pmid>18729783</pmid><doi>10.1086/591467</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-1899 |
ispartof | The Journal of infectious diseases, 2008-10, Vol.198 (7), p.984-993 |
issn | 0022-1899 1537-6613 |
language | eng |
recordid | cdi_proquest_miscellaneous_69522093 |
source | MEDLINE; JSTOR Archive Collection A-Z Listing; Oxford University Press Journals All Titles (1996-Current); Alma/SFX Local Collection |
subjects | Acute Disease Antibodies Antibodies, Viral - blood Biological and medical sciences Blood Blood donation Blood Donors Blood transfusion Disease transmission Fundamental and applied biological sciences. Psychology Humans Infections Infectious diseases Medical sciences Microbiology Miscellaneous Neutralization Tests Nucleic Acid Amplification Techniques RNA RNA, Viral - blood Specimens Transfusion Reaction Viremia Virology Viruses West Nile Fever - immunology West Nile Fever - virology West Nile virus West Nile virus - immunology West Nile virus - isolation & purification |
title | Virus and Antibody Dynamics in Acute West Nile Virus Infection |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T09%3A03%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Virus%20and%20Antibody%20Dynamics%20in%20Acute%20West%20Nile%20Virus%20Infection&rft.jtitle=The%20Journal%20of%20infectious%20diseases&rft.au=Busch,%20Michael%20P.&rft.date=2008-10-01&rft.volume=198&rft.issue=7&rft.spage=984&rft.epage=993&rft.pages=984-993&rft.issn=0022-1899&rft.eissn=1537-6613&rft.coden=JIDIAQ&rft_id=info:doi/10.1086/591467&rft_dat=%3Cjstor_proqu%3E40254224%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=21042800&rft_id=info:pmid/18729783&rft_jstor_id=40254224&rfr_iscdi=true |